PHARMACOKINETIC MODELING OF BIDIRECTIONAL TRANSFER DURING PERITONEAL-DIALYSIS

被引:17
作者
JANICKE, DM
MORSE, GD
APICELLA, MA
JUSKO, WJ
WALSHE, JJ
机构
[1] SUNY BUFFALO,ERIE CTY MED CTR,DIV RENAL,462 GRIDER ST,BUFFALO,NY 14215
[2] SUNY BUFFALO,SCH MED,DEPT MED,BUFFALO,NY 14215
[3] SUNY BUFFALO,SCH MED,DEPT PHARMACEUT,BUFFALO,NY 14215
[4] SUNY BUFFALO,SCH PHARM,DEPT PHARM,BUFFALO,NY 14215
关键词
D O I
10.1038/clpt.1986.165
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:209 / 218
页数:10
相关论文
共 28 条
[1]   PHARMACOKINETICS OF CEFAMANDOLE USING A HPLC ASSAY [J].
AZIZ, NS ;
GAMBERTOGLIO, JG ;
LIN, ET ;
GRAUSZ, H ;
BENET, LZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (02) :153-164
[2]   CEFAZOLIN AND CEPHALEXIN KINETICS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BUNKE, CM ;
ARONOFF, GR ;
BRIER, ME ;
SLOAN, RS ;
LUFT, FC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (01) :66-72
[3]   TOBRAMYCIN KINETICS DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BUNKE, CM ;
ARONOFF, GR ;
BRIER, ME ;
SLOAN, RS ;
LUFT, FC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :110-116
[4]   PHARMACOKINETICS OF CEFTIZOXIME IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BURGESS, ED ;
BLAIR, AD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) :237-239
[5]  
GAMBERTOGLIO JG, 1979, CLIN PHARMACOL THER, V26, P592
[6]   CEFTIZOXIME ELIMINATION KINETICS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
GROSS, ML ;
SOMANI, P ;
RIBNER, BS ;
RAEADER, R ;
FREIMER, EH ;
HIGGINS, JT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :673-680
[7]   CONVERSION OF CEFAMANDOLE NAFATE TO CEFAMANDOLE SODIUM [J].
INDELICATO, JM ;
WILHAM, WL ;
CERIMELE, BJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (08) :1175-1178
[8]  
JUSKO WJ, 1976, KIDNEY INT, V9, P430, DOI 10.1038/ki.1976.53
[9]  
JUSKO WJ, 1980, APPLIED PHARMACOKINE
[10]   INTRAPERITONEAL AND INTRAVENOUS CEFOPERAZONE KINETICS DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
KELLER, E ;
JANSEN, A ;
PELZ, K ;
HOPPESEYLER, G ;
SCHOLLMEYER, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) :208-213